At the 20th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD) in ...

Infection with Japanese encephalitis virus, a mosquito-borne flavivirus, was identified in a patient who received a liver ...

As India’s healthcare landscape evolves with cutting-edge diagnostic solutions, Chennai is set to witness a transformative development in screening with the lauching of Mispa i60 that offers a simple ...

Neuberg Diagnostics has introduced the Mispa i60 in Chennai for Alzheimer’s screening through a blood test. The test uses a ...

A new class of biomarker tests are able to diagnose some Alzheimer's cases. The next step would be predicting it: Here's ...

An international consortium has achieved a major breakthrough in the diagnosis of neurological diseases. In a recent ...

Phase 2 TBCRC049 trial results show tucatinib triplet therapy improves survival in HER2+ breast cancer patients with ...

Scientists have discovered a new quantitative biomarker in lumbar fluid that is helping doctors to diagnose Parkinson's ...

Can a spinal fluid test diagnose Parkinson’s? Researchers have identified DOPA decarboxylase as a key biomarker that separates Parkinson’s and Lewy body dementia from other forms of cognitive decline.

Belay Diagnostics announced the publication of a new retrospective study demonstrating that its Summit and Vantage tests provided meaningful clinical impact in 82% of CNS lymphoma cases evaluated. The ...

Belay Diagnostics announced the publication of a new retrospective study demonstrating that its Summit and Vantage tests ...